Posted by Michael Wonder on 02 Jun 2023
Coherus announces industry wide lowest list price for adalimumab biosimilar Yusimry (adalimumab-aqvh) launching in July 2023
1 June 2023 - List price of $995 per carton for two 40 mg/0.8 mL auto-injectors.
Coherus BioSciences today announced that the company plans to launch Yusimry (adalimumab-aqvh) in July 2023 with a list price of $995 per carton (2 x 40 mg/0.8 mL auto-injectors), the lowest price announced to date of any adalimumab offering in the United States.
With Humira currently priced at $6,922 per carton of two auto-injectors, the Yusimry price will represent about an 85% discount from the originator.
